Jeffrey Anderson, MD
Pain Medicine · Sartell, MNNPI 1942434436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,679 of the $4,422 with a category attached, or 60.6%. 11 manufacturers reported payments, led by Si-bone, Inc. at 32.8% of the total. Reporting peaked in 2024 at $1,737 and has fallen 88.6% since, to $197 in 2025.
Across 116 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$1K
- Abbott$936
- Relievant Medsystems, Inc.$923
- Boston Scientific$797
- Vertos Medical, Inc.$90
- Nevro Corp.$70
- plus $154 from 5 others
What the payments were for
- Travel & lodging$1,70339%
- Food & beverage$2,67961%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 9 | $1,452 |
| Abbott | 48 | $936 |
| Relievant Medsystems, Inc. | 11 | $923 |
| Boston Scientific | 33 | $797 |
| Vertos Medical, Inc. | 3 | $90 |
| Nevro Corp. | 4 | $70 |
| Curonix LLC | 3 | $49 |
| AbbVie | 2 | $44 |
| SPR Therapeutics, Inc | 1 | $30 |
| Mindray DS USA, Inc. | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,058
- IFUSE IMPLANT SYSTEM$1,118
- SPECTRA WAVEWRITER$146
How this compares
$4,422 in reported general payments places this provider in the 65th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 31 | $281 |
| Cephalexin | 49 | $245 |
| Clindamycin Hcl | 15 | $128 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $126 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Sartell
- Adam RuppSartell$976
- Richard StaynerEdina$105K
- David SchultzEdina$99K
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
- Ronald BoedingMaple Grove$68K
- Matthew ThorsonEdina$59K
- Sherri HaasEdina$51K
- Cody FosterCoon Rapids$36K
- Katelyn Parker-McgillAlexandria$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.